Biologic and Physical Principles of Total Body Irradiation for Allogeneic and Autologous Bone Marrow Transplantation in Children with Leukemia and Lymphoma
Following Roentgen’s discovery of x-rays in the twilight of the nineteenth century, only a decade or so elapsed before the birth of total body irradiation (TBI), described by Dessauer in 1907 as the “x-ray bath.” In 1927, Teschendorf first described the favorable results he had achieved using TBI in the treatment of the lymphomas. Five years later, Heublein reported on a group of patients with lymphoma, Hodgkin’s disease, and leukemia treated with TBI at Memorial Hospital in New York. In the 1990s, we are still struggling with the nuances of TBI and, in particular, how it is best used in conditioning regimens for bone marrow trasplantation (BMT). The relatively new art of BMT remains fraught with complex issues, and the increasing use of and lymphomas and its emerging role in the treatment of solid tumors have led to a reexamination of the effects of various conditioning regimens, not only in terms of tumor cell kill and prevention of rejection, but also in relation to long-term organ toxicity. Prior to receiving TBI as part of their conditioning regimens for BMT, children have often been exposed to various agents such as cyclophosphamide and cisplatin, causing subclinical damage to such organs as kidney and lung which must be factored into considerations of long-term organ toxicity.
KeywordsToxicity Europe Lymphoma Leukemia Fractionation
Unable to display preview. Download preview PDF.
- Corvo R, Frassoni F, Franzone P et al. (1989) Irradiazione corporea totale frazionata e iperfrazionata nel condizionamento del trapianto di midollo osseo allogenico nella leucemia linfatica acuta. Risultati. Radio Med (Torino) 78: 367–372Google Scholar
- Cosset JM, Baume D, Pico JL et al. (1989) single-dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a nonrandomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 15: 151–160Google Scholar
- Kimler BF, Park CH, Yakar D, Mies RM (1984) Lack of recovery from radiation-induced sublethal damage in human hematopoietic cells. Br J Cancer 49 [Suppl VI]: 221–225Google Scholar
- Moulder JE, Fish BL, Holcenberg JS, Cheng M (1988) Effect of total-body irradiation with bone marrow transplantation on toxicity of cisplatin. In: Interaction of radiation therapy and chemotherapy. NCI Monogr 6: 29–33Google Scholar
- Stewart FA, Luts A, Oussoren Y, Begg AC, Dewit L, Bartelink H (1988) Renal damage in mice after treatment with cisplatin and X-rays: comparison of fractionated and single-dose studies. In: Interaction of radiation therapy and chemotherapy. NCI Monogr 6: 23–27Google Scholar
- Thames HD, Hendry JH (1987) Fractionation in radiotherapy. Taylor and Francis, LondonGoogle Scholar
- Travis EL, Pouzet M-T, Yan R, Fang M-A (1990) Radiation response of mouse lung previously treated with cyclophosphamide: single dose and fractionation response. Third International Conference on the Interaction of Radiation Therapy and Systemic Therapy, 9–12 March 1990. The Asilomar Conference Center, Monterey, California, pp 4–2 through 4–2CGoogle Scholar